NCT05133245View on ClinicalTrials.gov

PHACE - Prospective Genetic Investigation

Enrolling by invitationOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions

PHACE Syndrome

Interventions

OTHER

Diagnostic study only

Diagnostic study only

Trial Locations (1)

37232

Vanderbilt Eye Institute, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER